Enfusion Inc. (ENFN)
10.76
-0.04 (-0.37%)
At close: Apr 17, 2025, 3:59 PM
10.61
-1.37%
After-hours: Apr 17, 2025, 08:00 PM EDT
Enfusion Revenue Breakdown
| Period Ending | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Managed services Revenue | 3.08M | 3.18M | 6.08M | 2.94M | 2.74M | 2.69M | 2.5M | 2.4M | 2.23M | 1.89M |
| Managed services Revenue Growth | -3.12% | -47.78% | +106.59% | +7.33% | +1.97% | +7.47% | +4.51% | +7.44% | +17.99% | n/a |
| Other Revenue | 302K | 186K | 848K | 166K | 229K | 22K | 694K | 584K | 360K | 19K |
| Other Revenue Growth | +62.37% | -78.07% | +410.84% | -27.51% | +940.91% | -96.83% | +18.84% | +62.22% | +1794.74% | n/a |
| Platform subscriptions Revenue | 47.79M | 44.69M | 83.91M | 39.61M | 38M | 37.8M | 35.95M | 33.56M | 31.55M | 27.14M |
| Platform subscriptions Revenue Growth | +6.93% | -46.74% | +111.84% | +4.24% | +0.51% | +5.15% | +7.13% | +6.37% | +16.27% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|
| United States Revenue | 104.5M | 92.8M | 71.9M |
| United States Revenue Growth | +12.61% | +29.07% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 25M | 24.69M | 26.44M | 22.67M | 22.22M | 21.6M | 18.56M | 21.07M | 20.37M | 25.88M | 30.73M | 167.63M | 13.45M | 11.72M | 9.54M | 26.63M | 6.58M | 6.31M | 6.31M |
| Selling, General, and Administrative Revenue Growth | +1.25% | -6.60% | +16.65% | +1.99% | +2.87% | +16.40% | -11.93% | +3.45% | -21.27% | -15.78% | -81.67% | +1146.61% | +14.73% | +22.87% | -64.17% | +304.84% | +4.30% | 0.00% | n/a |
| Research and Development Revenue | 6.84M | 6.1M | 6.55M | 6.06M | 4.94M | 4.46M | 4.43M | 4.78M | 3.86M | 3.72M | 4.8M | 146.56M | 2.6M | 2.04M | 2.2M | 1.8M | 1.64M | 1.44M | 1.44M |
| Research and Development Revenue Growth | +12.24% | -6.95% | +8.08% | +22.77% | +10.60% | +0.74% | -7.20% | +23.58% | +3.82% | -22.49% | -96.72% | +5536.77% | +27.39% | -7.31% | +22.54% | +9.44% | +14.07% | 0.00% | n/a |
| Sales and Marketing Revenue | 6.22M | 6.02M | 6.22M | 5.55M | 5.5M | 5.28M | 4.09M | 6M | 7.28M | 7.58M | 8.43M | 39.4M | 4.9M | 4.26M | 3.16M | 3.31M | 2.07M | 2.27M | 2.27M |
| Sales and Marketing Revenue Growth | +3.32% | -3.15% | +11.98% | +0.89% | +4.28% | +29.15% | -31.91% | -17.55% | -3.92% | -10.16% | -78.60% | +703.96% | +14.94% | +35.02% | -4.65% | +60.15% | -9.04% | 0.00% | n/a |